|
|
Hi there,
Last week, I asked you which big tech co (FAMGA) had the least fun CEO gig. There wasn’t much debate.
But more on that later.
Let's talk about the $52B clinical trials market.
Clinical trials are expensive (drug trials cost ~$1B) and take too long (nearly a decade).
As Covid-19 has shown, faster is possible — over the past year, more than 5,000 coronavirus-related clinical trials have been launched, leading to the development of several life-saving vaccines in under 1 year.
Now, big tech companies and startups, using a little technology called AI, are developing solutions to make clinical trials more efficient.
These include:
-
Using natural language processing to analyze medical records to better match patients with clinical trials
-
Deploying wearables and AI to monitor and track changes in patients while they’re at home
-
Creating platforms that span across the clinical trial process, providing researchers with more patient health data
Get an eye into the future of clinical trials, and how Covid-19 has affected clinical trial tech adoption, in our report.
|
|
|
|
|